260 related articles for article (PubMed ID: 21958383)
1. Platelet membrane phospholipid asymmetry: from the characterization of a scramblase activity to the identification of an essential protein mutated in Scott syndrome.
Lhermusier T; Chap H; Payrastre B
J Thromb Haemost; 2011 Oct; 9(10):1883-91. PubMed ID: 21958383
[TBL] [Abstract][Full Text] [Related]
2. A TMEM16F point mutation causes an absence of canine platelet TMEM16F and ineffective activation and death-induced phospholipid scrambling.
Brooks MB; Catalfamo JL; MacNguyen R; Tim D; Fancher S; McCardle JA
J Thromb Haemost; 2015 Dec; 13(12):2240-52. PubMed ID: 26414452
[TBL] [Abstract][Full Text] [Related]
3. TMEM16F is required for phosphatidylserine exposure and microparticle release in activated mouse platelets.
Fujii T; Sakata A; Nishimura S; Eto K; Nagata S
Proc Natl Acad Sci U S A; 2015 Oct; 112(41):12800-5. PubMed ID: 26417084
[TBL] [Abstract][Full Text] [Related]
4. Both TMEM16F-dependent and TMEM16F-independent pathways contribute to phosphatidylserine exposure in platelet apoptosis and platelet activation.
van Kruchten R; Mattheij NJ; Saunders C; Feijge MA; Swieringa F; Wolfs JL; Collins PW; Heemskerk JW; Bevers EM
Blood; 2013 Mar; 121(10):1850-7. PubMed ID: 23303820
[TBL] [Abstract][Full Text] [Related]
5. Survival protein anoctamin-6 controls multiple platelet responses including phospholipid scrambling, swelling, and protein cleavage.
Mattheij NJ; Braun A; van Kruchten R; Castoldi E; Pircher J; Baaten CC; Wülling M; Kuijpers MJ; Köhler R; Poole AW; Schreiber R; Vortkamp A; Collins PW; Nieswandt B; Kunzelmann K; Cosemans JM; Heemskerk JW
FASEB J; 2016 Feb; 30(2):727-37. PubMed ID: 26481309
[TBL] [Abstract][Full Text] [Related]
6. Impaired Ca2+-induced tyrosine phosphorylation and defective lipid scrambling in erythrocytes from a patient with Scott syndrome: a study using an inhibitor for scramblase that mimics the defect in Scott syndrome.
Dekkers DW; Comfurius P; Vuist WM; Billheimer JT; Dicker I; Weiss HJ; Zwaal RF; Bevers EM
Blood; 1998 Mar; 91(6):2133-8. PubMed ID: 9490700
[TBL] [Abstract][Full Text] [Related]
7. Scott syndrome, a bleeding disorder caused by defective scrambling of membrane phospholipids.
Zwaal RF; Comfurius P; Bevers EM
Biochim Biophys Acta; 2004 Mar; 1636(2-3):119-28. PubMed ID: 15164759
[TBL] [Abstract][Full Text] [Related]
8. Procoagulant expression in platelets and defects leading to clinical disorders.
Solum NO
Arterioscler Thromb Vasc Biol; 1999 Dec; 19(12):2841-6. PubMed ID: 10591659
[TBL] [Abstract][Full Text] [Related]
9. Regulatory mechanisms of transmembrane phospholipid distributions and pathophysiological implications of transbilayer lipid scrambling.
Bevers EM; Comfurius P; Dekkers DW; Harmsma M; Zwaal RF
Lupus; 1998; 7 Suppl 2():S126-31. PubMed ID: 9814689
[TBL] [Abstract][Full Text] [Related]
10. Phospholipid scramblase: an update.
Bevers EM; Williamson PL
FEBS Lett; 2010 Jul; 584(13):2724-30. PubMed ID: 20302864
[TBL] [Abstract][Full Text] [Related]
11. Roles and regulation of phospholipid scramblases.
Kodigepalli KM; Bowers K; Sharp A; Nanjundan M
FEBS Lett; 2015 Jan; 589(1):3-14. PubMed ID: 25479087
[TBL] [Abstract][Full Text] [Related]
12. Calcium-activated and apoptotic phospholipid scrambling induced by Ano6 can occur independently of Ano6 ion currents.
Kmit A; van Kruchten R; Ousingsawat J; Mattheij NJ; Senden-Gijsbers B; Heemskerk JW; Schreiber R; Bevers EM; Kunzelmann K
Cell Death Dis; 2013 Apr; 4(4):e611. PubMed ID: 23618909
[TBL] [Abstract][Full Text] [Related]
13. Expression of proteins controlling transbilayer movement of plasma membrane phospholipids in the B lymphocytes from a patient with Scott syndrome.
Zhou Q; Sims PJ; Wiedmer T
Blood; 1998 Sep; 92(5):1707-12. PubMed ID: 9716599
[TBL] [Abstract][Full Text] [Related]
14. Scott syndrome erythrocytes contain a membrane protein capable of mediating Ca2+-dependent transbilayer migration of membrane phospholipids.
Stout JG; Bassé F; Luhm RA; Weiss HJ; Wiedmer T; Sims PJ
J Clin Invest; 1997 May; 99(9):2232-8. PubMed ID: 9151796
[TBL] [Abstract][Full Text] [Related]
15. Activated scramblase and inhibited aminophospholipid translocase cause phosphatidylserine exposure in a distinct platelet fraction.
Wolfs JL; Comfurius P; Rasmussen JT; Keuren JF; Lindhout T; Zwaal RF; Bevers EM
Cell Mol Life Sci; 2005 Jul; 62(13):1514-25. PubMed ID: 15971000
[TBL] [Abstract][Full Text] [Related]
16. TMEM16F forms a Ca2+-activated cation channel required for lipid scrambling in platelets during blood coagulation.
Yang H; Kim A; David T; Palmer D; Jin T; Tien J; Huang F; Cheng T; Coughlin SR; Jan YN; Jan LY
Cell; 2012 Sep; 151(1):111-22. PubMed ID: 23021219
[TBL] [Abstract][Full Text] [Related]
17. Transmembrane phospholipid distribution in blood cells: control mechanisms and pathophysiological significance.
Bevers EM; Comfurius P; Dekkers DW; Harmsma M; Zwaal RF
Biol Chem; 1998; 379(8-9):973-86. PubMed ID: 9792430
[TBL] [Abstract][Full Text] [Related]
18. Regulatory mechanisms in maintenance and modulation of transmembrane lipid asymmetry: pathophysiological implications.
Bevers EM; Comfurius P; Zwaal RF
Lupus; 1996 Oct; 5(5):480-7. PubMed ID: 8902787
[TBL] [Abstract][Full Text] [Related]
19. Regulation of TMEM16A/ANO1 and TMEM16F/ANO6 ion currents and phospholipid scrambling by Ca
Schreiber R; Ousingsawat J; Wanitchakool P; Sirianant L; Benedetto R; Reiss K; Kunzelmann K
J Physiol; 2018 Jan; 596(2):217-229. PubMed ID: 29134661
[TBL] [Abstract][Full Text] [Related]
20. Single-molecule analysis of phospholipid scrambling by TMEM16F.
Watanabe R; Sakuragi T; Noji H; Nagata S
Proc Natl Acad Sci U S A; 2018 Mar; 115(12):3066-3071. PubMed ID: 29507235
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
